The drug manufacturer Terapia Cluj has a EUR 5.5 million investment budget for the financial year 2022-2023.
“We have around EUR 5.5 million for investments. We aim to expand the logistics hub, the goods warehouse and a logistics hub for sale in Europe and the Euro-Asian area. We want to expand the clinical trial unit and renovate the office building, plus some investment in equipment, the production process is becoming more and more sophisticated. These investments are budgeted for the financial year 2022-2023, related to the approvals and the construction schedule, but in the next two years we plan to finalize them,” said Dragoş Damian, CEO of Terapia Cluj.
Source: ZF.ro.
